PT - JOURNAL ARTICLE AU - Foy, Brody H AU - Petherbridge, Rachel AU - Roth, Maxwell AU - Mow, Christopher AU - Patel, Hasmukh R AU - Patel, Chhaya H AU - Ho, Samantha N AU - Lam, Evie AU - Karczewski, Konrad J AU - Tozzo, Veronica AU - Higgins, John M TI - Hematologic setpoints are a stable and patient-specific deep phenotype AID - 10.1101/2023.09.26.23296146 DP - 2023 Jan 01 TA - medRxiv PG - 2023.09.26.23296146 4099 - http://medrxiv.org/content/early/2023/09/28/2023.09.26.23296146.short 4100 - http://medrxiv.org/content/early/2023/09/28/2023.09.26.23296146.full AB - The complete blood count is an important screening tool for healthy adults and is the most commonly ordered test at periodic physical exams. However, results are usually interpreted relative to one-size-fits-all reference intervals, undermining the goal of precision medicine to tailor medical care to the needs of individual patients based on their unique characteristics. Here we show that standard complete blood count indices in healthy adults have robust homeostatic setpoints that are patient-specific and stable, with the typical healthy adult’s set of 9 blood count setpoints distinguishable from 98% of others, and with these differences persisting for decades. These setpoints reflect a deep physiologic phenotype, enabling improved detection of both acquired and genetic determinants of hematologic regulation, including discovery of multiple novel loci via GWAS analyses. Patient-specific reference intervals derived from setpoints enable more accurate personalized risk assessment, and the setpoints themselves are significantly correlated with mortality risk, providing new opportunities to enhance patient-specific screening and early intervention. This study shows complete blood count setpoints are sufficiently stable and patient-specific to help realize the promise of precision medicine for healthy adults.Competing Interest StatementThe authors have declared no competing interest.Funding StatementJMH reports funding from the National Institutes of Health (grant IDs: R01HD104756; R01DK123330).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Institutional review board of Massachusetts General Hospital gave ethical approval for this workI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesDue to restrictions on sharing protected health information, individual patient data has not been shared. Supplemental methods, figures and tables are given in Supplemental File 1. GWAS summary data has been uploaded to the GWAS catalog and is available at accession number (to be inserted in later pre-print version). Data for significant hits and loci is given in Supplemental File 2. Code for calculating of setpoints is included in Supplemental File 3.